FDG-PET for response assessment of malignant lymphoma

Research output: Contribution to journalReview articlepeer-review

Abstract

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is a promising functional imaging test for patients with malignant lymphoma (ML) , and has gained wide usage during the last decade. In 2007, an International Harmonization Project (IHP) proposed revised response criteria for evaluating therapy responses in ML and consensus recommendations of FDG-PET for this purpose. The relevance of the response criteria and consensus recommendations should be validated in prospective clinical trials. Clinicians should utilize them cautiously in clinical practice because clinical data on decision making depending on these guidelines are still limited.

Original languageEnglish
Pages (from-to)418-424
Number of pages7
JournalJapanese Journal of Clinical Radiology
Volume52
Issue number3
Publication statusPublished - 13-04-2007
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'FDG-PET for response assessment of malignant lymphoma'. Together they form a unique fingerprint.

Cite this